Cargando…
Formulation development, in vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin
Insulin-dependent diabetic patients have to count on the administration of painful and discomforting insulin injections. However, inadequate insulin absorption and the risk of insulin level escalation in the blood are some disadvantages associated with insulin therapy. Thus, the current study intend...
Autores principales: | Rathore, Priyanka, Mahor, Alok, Jain, Surendra, Haque, Anzarul, Kesharwani, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058365/ https://www.ncbi.nlm.nih.gov/pubmed/35519724 http://dx.doi.org/10.1039/d0ra07640f |
Ejemplares similares
-
QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
por: Kesharwani, Prashant, et al.
Publicado: (2021) -
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
por: Zamboulis, Alexandra, et al.
Publicado: (2020) -
Formulation and In-Vitro/Ex-Vivo Characterization of Pregelled Hybrid Alginate–Chitosan Microparticles for Ocular Delivery of Ketorolac Tromethamine
por: Fathalla, Zeinab, et al.
Publicado: (2023) -
Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity
por: Bin-Jumah, May, et al.
Publicado: (2020) -
Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate
por: Kalam, Mohd Abul, et al.
Publicado: (2022)